Medical Decision Making

Papers
(The median citation count of Medical Decision Making is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Stability of Stated Preferences: Vaccine Priority Setting before and during the First COVID-19 Lockdown38
Variation in Patient-Reported Decision-Making Roles in the Last Year of Life among Patients with Metastatic Cancer: A Longitudinal Study32
Discordant Care and Decision Quality: Patients’ Reasons for Not Receiving Their Initial Test of Choice in Colorectal Cancer Screening30
Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models28
Health Utilities in People with Hepatitis C Virus Infection: A Study Using Real-World Population-Level Data25
Do Worse than Dead Values Add Relevant Information in (Composite) Time-Tradeoff Valuations?22
A Nonparametric Approach for Estimating the Effective Sample Size in Gaussian Approximation of Expected Value of Sample Information22
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model20
Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry19
Integrating Vaginal Microbiome Test Results into Shared Decision Making during In Vitro Fertilization Care18
Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis18
A Bayesian Modeling Framework for Health Care Resource Use and Costs in Trial-Based Economic Evaluations16
A New Integrative Modeling Approach for Generating Counterfactual Projections of Colorectal Cancer Incidence Rates in the Absence of Organized Screening in Australia14
Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics14
Abstracts 2022 North American Meeting for the Society of Medical Decision Making, October 23-26, 202214
Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort Study13
How Do People Process Different Representations of Statistical Information? Insights into Cognitive Effort, Representational Inconsistencies, and Individual Differences13
Constrained Optimization for Decision Making in Health Care Using Python: A Tutorial13
Segmenting the Population and Estimating Transition Probabilities Using Data on Health and Health-Related Social Service Needs from the US Health and Retirement Study13
How Much Information Is Too Much? An Experimental Examination of How Information Disclosures May Unintentionally Encourage the Withholding of Health Information13
Accurate EVSI Estimation for Nonlinear Models Using the Gaussian Approximation Method12
Development of a Microsimulation Model to Project the Future Prevalence of Childhood Cancer in Ontario, Canada12
Natural Frequencies Improve Public Understanding of Medical Test Results: An Experimental Study on Various Bayesian Inference Tasks with Multiple Scoring Methods and Non-Bayesian Reasoning Strategies12
Veterans’ Lung Cancer Risk Conceptualizations versus Lung Cancer Screening Shared Decision-Making Conversations with Clinicians: A Qualitative Study12
Patients’ Attitude toward Less Frequent Surveillance of Low-Risk Pancreatic Cysts: A Multicenter European Cohort Study11
End-of-Life Preferences: A Randomized Trial of Framing Comfort Care as Refusal of Treatment in the Context of COVID-1911
Comparative Assessment of Reimbursement Recommendations by NICE and HAS for Oncology New Medicines Indicated for the Treatment of Solid Tumors from 2015 to 202111
Using Discrete Choice Experiments (DCEs) to Compare Social and Personal Preferences for Health and Well-Being Outcomes11
45 th Annual North American Meeting of the Society for Medical Decision Making, Philadelphia, Pennsylvania, United States, 22-25 October 202311
Potential Paths Forward from “On Representations and Quantifications of Uncertainty”10
Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer10
Withdrawing versus Withholding Treatments in Medical Reimbursement Decisions: A Study on Public Attitudes9
Medical Decision Making and MDM Policy & Practice Reviewers , 20229
Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study9
Communicating the Imperfect Diagnostic Accuracy of COVID-19 Rapid Antigen Self-Tests: An Online Randomized Experiment9
Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making9
General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations9
Recalibrating an Established Microsimulation Model to Capture Trends and Projections of Colorectal Cancer Incidence and Mortality9
Medical Decision Making and MDM Policy & Practice Reviewers , 20239
Machine Learning for Intensive Care Unit Length-of-Stay Prediction: A Simulation-Based Approach to Bed Capacity Management9
Nonchoice Surgical Decision Making among Patients with Cancer: A Narrative Review8
Collecting Physicians’ Preferences on Medical Devices: Are We Doing It Right? Evidence from Italian Orthopedists Using 2 Different Stated Preference Methods8
Comparison of Preferences and Data Quality between Discrete Choice Experiments Conducted in Online and Face-to-Face Respondents8
Do Patient Preferences and Treatment Beliefs Explain Patterns of Antihypertensive Medication Nonadherence? A Discrete Choice Experiment8
Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame8
Identifying Decisional Needs for Adult Tracheostomy and Prolonged Mechanical Ventilation Decision Making to Inform Shared Decision-Making Interventions8
A Parsimonious Approach to Remediate Concerns about QALY-Based Discrimination7
Different Interventions for COVID-19 Primary and Booster Vaccination? Effects of Psychological Factors and Health Policies on Vaccine Uptake7
Shared Decision Making for Elective Surgical Procedures in Older Adults with and without Cognitive Insufficiencies7
Using a Sample Size Calculation Framework for Clinical Prediction Models When Developing and Selecting Mapping Algorithms Based on Linear Regression7
Communicating on Vaccine Benefit-Risk Ratios: A Discrete-Choice Experiment among Health Care Professionals and the General Population in France7
Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks7
Weight Status Transitions and Validation of an Obesity Model for Aboriginal and Torres Strait Islander Children and Adolescents7
So You’ve Got a High AUC, Now What? An Overview of Important Considerations when Bringing Machine-Learning Models from Computer to Bedside6
Lottery or Triage? Controlled Experimental Evidence from the COVID-19 Pandemic on Public Preferences for Allocation of Scarce Medical Resources6
Postpartum Sterilization after a Preterm Delivery Is Not Associated with Decision Regret6
Estimating Change in Health-Related Quality of Life before and after Stroke: Challenges and Possible Solutions6
Reinforcement Learning-Based Control of Epidemics on Networks of Communities and Correctional Facilities6
The Role of Smoking Status in Making Risk-Informed Diagnostic Decisions in the Lung Cancer Pathway: A Qualitative Study of Health Care Professionals and Patients6
Pressured or Voluntary? Motivations for Vaccination during the COVID-19 Pandemic and Future Health-Protective Behaviors6
Linking Patient Perceptions of Shared Decision Making to Satisfaction in Lung Cancer Screening Decisions6
Motivated Interpretations of Survival Rates in Icon Arrays: An Issue of Frequency Format?6
Optimizing Face Validity and Clinical Relevance of a Mathematical Population Cancer Epidemiology Model Using a Novel Advisory Group Approach6
Identifying Patterns in Preoperative Communication about High-Risk Surgical Intervention: A Secondary Analysis of a Randomized Clinical Trial6
STEER: Open Access Resources for Conducting Structured Expert Elicitation for Health Care Decision Making6
Corrigendum to “Calculating the Expected Net Benefit of Sampling for Survival Data: A Tutorial and Case Study”6
Modeling Disability-Adjusted Life-Years for Policy and Decision Analysis6
Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis6
Shared Decision Making among Patients with Chronic Conditions in France: A Cross-Sectional Survey in the ComPaRe E-Cohort5
Influence of Anecdotes of IVF Success on Treatment Decision Making: An Online Randomized Controlled Trial5
Optimal Epidemic Control under Uncertainty: Tradeoffs between Information Collection and Other Actions5
A Prospective Cohort Study of Medical Decision-Making Roles and Their Associations with Patient Characteristics and Patient-Reported Outcomes among Patients with Heart Failure5
Values Clarification Methods in Decision Support Tools for Lung Cancer Screening: A Systematic Review and Content Analysis5
A Tutorial on Net Benefit Regression for Real-World Cost-Effectiveness Analysis Using Censored Data from Randomized or Observational Studies5
Attitudes on Equal Health Care Access versus Efficient Clinical Decisions across a Not-for-Profit Health Care System5
Closed-Form Solution of the Unit Normal Loss Integral in 2 Dimensions, with Application in Value-of-Information Analysis5
Perceptions of COVID-19 Risk: How Did People Adapt to the Novel Risk?5
Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up5
Modeling Recurrent Events: A Tutorial Based on Relapse and Remitting Episodes during Medication-Assisted Treatment for Opioid Use Disorder5
Call for Papers on the Interface between Human Users and Machine Learning Models in Medical Decision Making5
How Should Doctors Frame the Risk of a Vaccine’s Adverse Side Effects? It Depends on How Trustworthy They Are5
The Effect of Patient Decision Aid Attributes on Patient Outcomes: A Network Meta-Analysis of a Systematic Review5
Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations5
Does Messaging for Reducing Breast Cancer Overscreening in Older Women Have Differential Responses among Medical Minimizers and Maximizers?5
Population Health and Health Inequality Impacts of the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in England5
Through the Eyes of Patients: The Effect of Training General Practitioners and Nurses on Perceived Shared Decision-Making Support5
COVID-19 and Politically Motivated Reasoning5
Incorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines5
Cancer Patients’ Experiences of Burden when Involved in Treatment Decision Making5
Do Moral Views Change during a Crisis? An Experiment on Health Care Priority Setting4
The Health Impact of Waiting for Elective Procedures in the NHS in England: A Modeling Framework Applied to Coronary Artery Bypass Graft and Total Hip Replacement4
Perceptions of Clinical Experience and Scientific Evidence in Medical Decision Making: A Survey of a Stratified Random Sample of Swedish Health Care Professionals4
The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations4
The Blurred Lines of HTA Agency Decision Making4
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013–20234
Perceived Penalties for Sharing Patient Beliefs with Health Care Providers4
Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline4
Health State Values Should Not Be Used as Minimal Important Differences4
Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data4
The Use of Nudge Strategies in Improving Physicians’ Prescribing Behavior: A Systematic Review and Meta-analysis4
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information4
Icon Arrays for Medical Risk Communication: Do Icon Type and Color Influence Cardiovascular Risk Perception and Recall?4
Unclear Trajectory and Uncertain Benefit: Creating a Lexicon for Clinical Uncertainty in Patients with Critical or Advanced Illness Using a Delphi Consensus Process4
An Approach for Combining Clinical Judgment with Machine Learning to Inform Medical Decision Making: Analysis of Nonemergency Surgery Strategies for Acute Appendicitis in Patients with Multiple Long-T4
A Break from the Norm? Parametric Representations of Preference Heterogeneity for Discrete Choice Models in Health4
Feedback Loop Failure Modes in Medical Diagnosis: How Biases Can Emerge and Be Reinforced4
A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes–Chronic Kidney Disease Model4
A Microsimulation-Based Approach for Mitigating Societal Bias in Chronic Kidney Disease Data4
“Sensemaking” to Aid Shared Decision Making in Clinical Practice: A Personal Response to Information Overload and Decision Abdication4
Beyond Access: Prioritizing Equity during Discussions about Cancer Screening4
A Pragmatic Bayesian Adaptive Trial Design Based on the Value of Information: The Value-Driven Adaptive Design4
Persistent Challenges to a Single Diagnosis4
Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis3
Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models3
Organ Donation Decisions: When Deviating from the Status Quo Heightens Perceived Vulnerability3
Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab3
Shared Decision Making Is in Need of Effectiveness-Implementation Hybrid Studies3
Population Preferences for Treatment in Life-Limiting Illness: Valuing the Way Time Is Spent at the End of Life3
Can the General Public Be a Proxy for an “At-Risk” Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis3
Communicating Time-to-Event Treatment Effects in Randomized Trials: A Randomized Experiment among General Practitioners3
Uncertainty around Health State Values Used in Cost-Effectiveness Analysis: How It Arises and How to Deal with It3
Effect of Personalized Risk Messages on Patient Intent and Decision Making in Colorectal Cancer Screening: A Randomized Controlled Trial3
Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments3
A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when Incorporating Real-World Data3
Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains3
Impact of Limited Sample Size and Follow-up on Partitioned Survival and Multistate Modeling-Based Health Economic Models: A Simulation Study3
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty3
A Comparison of Ordered Categorical versus Discrete Choices within a Stated Preference Survey of Whole-Blood Donors3
Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology3
Are Pathologists Self-Aware of Their Diagnostic Accuracy? Metacognition and the Diagnostic Process in Pathology2
Corrigendum to “An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial”2
Bayesian Models with Spatial Correlation Improve the Precision of EQ-5D-5L Value Sets2
Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing2
Bias-Adjusted Predictions of County-Level Vaccination Coverage from the COVID-19 Trends and Impact Survey2
Development of a Naturalness Preference Scale2
Using Separate Single-Outcome Risk Presentations Instead of Integrated Multioutcome Formats Improves Comprehension in Discrete Choice Experiments2
Competencies for Pediatric Shared Decision Making: A Delphi Consensus Study2
Target Trial Emulation to Incorporate Real-World Data in the Estimation of the Clinical and Cost-Effectiveness of Biologic Treatment2
Mapping and Linking between the EQ-5D-5L and the PROMIS Domains in the United States2
The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England, France, and Australia between 2017 and 20222
Adaptation and Validation of the Psychological Consequences of Screening Questionnaire (PCQ) for Cognitive Screening in Primary Care2
Valuing the Dental Caries Utility Index in Australia2
Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening Programs2
Machine Learning Methods to Estimate Individualized Treatment Effects for Use in Health Technology Assessment2
Hospital Adoption of Diversity, Equity, and Inclusion (DEI) Disaggregated Data for Organizational Decision Making2
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis2
Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway2
Stability of Willingness to Pay: Does Time and Treatment Allocation in a Randomized Controlled Trial Influence Willingness to Pay?2
Utilities Estimated from PROMIS Scales for Cost-Effectiveness Analyses in Stroke2
On Representations and Quantifications of Uncertainty2
Investigating Bias in the Evaluation Model Used to Evaluate the Effect of Breast Cancer Screening: A Simulation Study2
Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models2
Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning–Based Metamodeling: A Case of Hepatitis C Treatment2
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial2
Danish Women Make Decisions about Participation in Breast Cancer Screening prior to Invitation Information: An Online Survey Using Experimental Methods2
The “Stock of Time” Method: A New Approach to Calculate Indirect Costs and Benefits in Economic Evaluations2
Modeling the Impact of Multicancer Early Detection Tests: A Review of Natural History of Disease Models2
How Inclusive Are Patient Decision Aids for People with Limited Health Literacy? An Analysis of Understandability Criteria and the Communication about Options and Probabilities2
18th Biennial European Conference of the Society for Medical Decision Making, Berlin, Germany, May 21–23, 20232
The Effect of a Surgeon Communication Strategy on Treatment Preference for Thyroid Cancer: A Randomized Trial2
Hypothetical Bias in the SG and TTO2
Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study2
Evaluating and Modeling Neighborhood Diversity and Health Using Electronic Health Records2
Informed Decision Making for Anticoagulation Therapy for Atrial Fibrillation2
Valuation of the EQ-5D-Y-5L Using DCE Methods That Account for Nonlinear Time Preferences2
A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study2
A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example2
A Tutorial on Discrete Event Simulation Models Using a Cost-Effectiveness Analysis Example in R2
Causal Estimation of Long-term Intervention Cost-effectiveness Using Genetic Instrumental Variables: An Application to Cancer2
Process for Rapid Co-development of a Decision Aid Prototype for Population-wide Cancer Screening2
AI Aversion: Do People Trust and Accept Artificial Intelligence Risk Calculator Recommendations?2
0.13100290298462